MedTech Dive September 13, 2024
Silk Road Medical said in a securities filing that the antitrust waiting period expired Thursday evening, opening the door to complete the $1.26 billion deal.
Dive Brief:
- Boston Scientific and Silk Road Medical expect their $1.26 billion merger to close in the “coming days,” nearly three months after the acquisition was announced.
- Silk Road, which makes stroke prevention devices, said Friday in a federal securities filing that the merger waiting period expired late Thursday, allowing the companies to complete the deal. In August, Boston Scientific resubmitted its merger filing to give the Federal Trade Commission additional time to review the acquisition proposal, which triggered a new waiting period.
- Boston Scientific confirmed in an emailed statement that it expects to...
Today's Sponsors
Today's Sponsor